Lykos Therapeutics Funding: $100M Raised, Series A (2024)
Lykos Therapeutics is based in Cranbury. It has raised $100M in total funding. Latest round: Series A.
Lykos Therapeutics funding overview
Lykos Therapeutics is based in Cranbury. Lykos Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Lykos Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Helena, Steven & Alexandra Cohen Foundation, True Ventures, Satori Neuro. 4 distinct backers are named across the disclosed rounds.
Lykos Therapeutics at a glance
Total raised
$100M
Latest round
Series A
Latest round date
January 2024
Headquarters
Cranbury
Notable investors
Helena, Steven & Alexandra Cohen Foundation, True Ventures, Satori Neuro
Frequently asked about Lykos Therapeutics funding
How much has Lykos Therapeutics raised?
Lykos Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Lykos Therapeutics?
Helena, Steven & Alexandra Cohen Foundation, True Ventures, Satori Neuro are named among the investors backing Lykos Therapeutics.
What was the latest Lykos Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Lykos Therapeutics based?
Lykos Therapeutics is based in Cranbury.
When did Lykos Therapeutics last raise?
The last disclosed Lykos Therapeutics round closed in January 2024 at Series A.
Round data for Lykos Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cranbury and backer lists below.
